期刊文献+

NF-κB超抑制物IκBαM重组腺病毒的构建 被引量:14

Construction of the recombinant adenovirus AdIκBαM
下载PDF
导出
摘要 目的 在克隆IκBα基因并构建IκBαM的基础上 ,构建重组腺病毒AdIκBαM。方法 将IκBαM克隆至穿梭质粒 ,线性化后与骨架质粒共同转染BJ5 183菌 ,构建重组腺病毒质粒。酶切及PCR法鉴定 ;将其线性化后转染 2 93细胞 ,观察绿色荧光以确定转染结果 ,以Westernblot法检测目的基因表达。结果 凝胶电泳及行酶切鉴定表明同源重组成功 ;PCR产物测序证明确为IκBαM ;以重组腺病毒质粒转染 2 93细胞 ,见绿色荧光 ;感染 2 93细胞得到大量病毒。结论 成功构建了IκBαM重组腺病毒 。 Objective To construct the adenoviral vector that expresses IκBαM gene for further study of the tumor gene therapy on the bases of successfully cloning Chinese IκBα gene and constructing IκBαM the super repressor form of the NF κB, and to study the roles of NF κB/ IκBα system. Methods The IκBαM gene was cloned to the shuttle plasmid Track CMV. The shuttle plasmids were linearized with Pme Ⅰ. Shuttle plasmid was co transform digested with adenoviral backbone vector to E.coli BJ5183 cells. The candidate clones were further tested by restriction nuclease digestion. Before transfection, recombinant adenoviral plasmids were digested with Pac Ⅰ. Then, the digested recombinant adenoviral plasmid was transfected to 293 cells with FuGENE TM 6 transfection reagent. Transfection viral productions were monitored by GFP(green fluorescent protein) expression. Presence of the recombinant adenoviruses was confirmed by PCR. Results The results show that we have successfully cloned the IκBαM gene to the plasmid Track CMV. The restriction analysis and the sequencing analysis of PCR product confirmed that correct recombinant adenoviral plasmid was constructed. 2 days after transfection, the fluorescence was observed in 293 cells. The expression of the IκBα gene was detected by Western blot. Conclusion We have constructed the recombinant adenovirus AdIκBαM. It will provide a solid basis for the study of IκBα mediated antitumor gene therapy and the roles of the NF κB /IκBα system.
出处 《免疫学杂志》 CAS CSCD 北大核心 2004年第1期65-69,73,共6页 Immunological Journal
基金 国家"8 63"计划项目 (20 0 1AA2 1 71 2 1) 国家自然科学基金面上资助项目 (30 0 70 2 97)
关键词 NF-ΚB IΚBΑ 腺病毒 基因治疗 NF-κB IκBα Adenovirus Gene therapy
  • 相关文献

参考文献4

二级参考文献23

  • 1[1]Baeuerle PA, Baltimore D. NF-κB: ten years after[J]. Cell, 199 6,87(4):13-20. 被引量:1
  • 2[2]May MJ, Ghosh S. Signal transduction through NF-κB[J].I mmunology Today, 1998,19(2):80-88. 被引量:1
  • 3[3]Tak PP, Firestein GS. NF-kappaB: a key role in inflammatory diseases [J]. J Clin Invest, 2001 ,107(1) :7-11. 被引量:1
  • 4[4]Waddick KG, Uckun FM. Innovative treatment programs against cancer:Ⅱ.Nuclear tactor-kappa B (NF-kappaB) as a molecular target [ J]. Biochem Pharmacol,1999,57(1): 9-17. 被引量:1
  • 5[5]Hayashi T, Faustman D. A role for NF-kappaB and the proteasom e in autoimmunity [J]. Arch Immunol Ther Exp, 2000, 48(5):353-365. 被引量:1
  • 6[6]McKinsey TA, Chu Z, Tedder TF, et al. Transcription factor NF -kappaB regulates inducible CD83 gene expression in activated T lymphocytes[J ]. Mol Immunol, 2000, 37(12,13):783-788. 被引量:1
  • 7[7]Eierman DF, Johnson CE, Haskill JS. Human monocyte inflammatory me diator gene expression is selectively regulated by adherence substrates[J]. J Immunol, 1989, 142(6): 1 970-1 976. 被引量:1
  • 8[8]Brown K, Gerstberger S, Carlson L, et al. Control of IκBα pr oteolysis by site-specific, signal-induced phosphory-lation [J]. Scienc e, 1995, 267(10): 1 485-1 488. 被引量:1
  • 9[9]Brockman JA, Scherer DC, McKinsey TA, et al. Coupling of a sig nal response domain in IκBα to multiple pathways for NF-κB activation [J]. Mol Cell Biol, 1995, 15(6): 2 809-2 818. 被引量:1
  • 10[10]Wang CY, Mayo MW, Baldwin AS. TNF-and cancer therapy-i nduced apoptosis: potentiation by inhibition of NF-κB[J]. Science, 1996, 274(5 288): 784-787. 被引量:1

共引文献39

同被引文献107

引证文献14

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部